Merck & Company, Inc. News Headlines

MRK 
$59.17
*  
0.32
0.54%
Get MRK Alerts
*Delayed - data as of Aug. 22, 2014  -  Find a broker to begin trading MRK now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Time To Take Profits?: 16 Dividend Stocks That Are Currently Overvalued (Part 1)
5/26/2014 4:22:00 AM - Seeking Alpha

The All-Defensive Team: 25 Low Beta Dividend Stocks For An Uncertain Market (Part 2)
5/25/2014 2:55:00 AM - Seeking Alpha

An Alternative Design For A Retirement Income Portfolio
5/23/2014 11:48:00 PM - Seeking Alpha

Celgene Gains Slightly on Management Changes - Analyst Blog
5/23/2014 4:12:00 PM - Zacks.com

Dow Movers: MRK, BA
5/22/2014 12:08:31 PM - BNK Invest

Medtronic Earnings Drags Medical Device ETF Lower - ETF News And Commentary
5/22/2014 12:00:08 PM - Zacks.com

Dogs Of The Dow Strategy Working So Far. What Should You Do Now?
5/21/2014 6:54:00 PM - Seeking Alpha

Invest In AbbVie's New Blockbuster Drug
5/21/2014 7:35:00 AM - Seeking Alpha

Notable ETF Inflow Detected - SPY, JNJ, MRK, ORCL
5/19/2014 11:01:54 AM - BNK Invest

The Merck-Bayer Deal Can Prove To Be A Growth Catalyst
5/19/2014 6:19:00 AM - Seeking Alpha

Must-know: Why Pfizer could up its offer for AstraZeneca
5/16/2014 9:00:00 AM - Market Realist

Why the proposed Pfizer-AstraZeneca deal could face challenges
5/15/2014 1:00:00 PM - Market Realist

Bristol-Myers Squibb: The Stock Is Overpriced
5/15/2014 12:49:00 PM - Seeking Alpha

Why AstraZeneca’s oncology pipeline is attractive to Pfizer
5/15/2014 9:00:00 AM - Market Realist

Merck Continues to Divest Ophthalmology Products - Analyst Blog
5/14/2014 5:00:00 PM - Zacks.com

Dow Snaps Five-Day Winning Streak, S&P 500 Faces Resistance
5/14/2014 4:21:15 PM - Schaeffer's Investment Research

The 5 Most Overvalued Dow Stocks
5/14/2014 3:25:00 PM - Seeking Alpha

Despite Disappointing Performance, Pfizer Pins Its Hope On These Drugs
5/14/2014 1:48:22 PM - Trefis

Dow Movers: IBM, MRK
5/14/2014 11:50:45 AM - BNK Invest

The must-know details of Pfizer’s offer to acquire AstraZeneca
5/13/2014 5:07:00 PM - Market Realist

Merck Sells Japan Eye-Treatment Rights
5/13/2014 10:35:00 AM - Fox Business

Tracking Irving Kahn's Kahn Brothers Portfolio - Q1 2014 Update
5/10/2014 6:37:00 AM - Seeking Alpha

After Hours Most Active for May 8, 2014 : LLY, BAC, QQQ, MSFT, ATML, RVT, MCP, SIRI, MRK, NEE^O, FB, OREX
5/8/2014 4:44:59 PM - NASDAQ.com News

Reversal of Fortune: Stocks Start Strong, Finish Weak
5/8/2014 4:17:34 PM - Schaeffer's Investment Research

Dow Movers: CVX, T
5/8/2014 12:20:16 PM - BNK Invest